Press Releases April 28, 2026 07:30 AM

Aveanna to Participate at the Barclays 30th Annual Leveraged Finance Conference

Aveanna Healthcare to Present at Barclays 30th Annual Leveraged Finance Conference

By Sofia Navarro
Share
Twitter Reddit Facebook LinkedIn
AVAH

Aveanna Healthcare Holdings Inc. announced its participation in the Barclays 30th Annual Leveraged Finance Conference, where its management will conduct investor meetings. The company provides a range of pediatric and adult healthcare services across 38 states, focusing on cost-effective care alternatives to hospitalization.

Aveanna to Participate at the Barclays 30th Annual Leveraged Finance Conference
AVAH
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Aveanna Healthcare is attending a major leveraged finance conference to engage with investors.
  • The company offers diverse healthcare services including nursing, rehabilitation, therapy, and case management across 38 states.
  • Services aim to reduce healthcare costs by providing alternatives to prolonged hospitalization.

ATLANTA, April 28, 2026 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (“Aveanna”) (NASDAQ: AVAH) today announced that its management team will attend the Barclays 30th Annual Leveraged Finance Conference in Austin, TX on May 19, 2026. Management will host 1x1 investor meetings that day.

About Aveanna Healthcare

Aveanna Healthcare is headquartered in Atlanta, Georgia and has locations in 38 states providing a broad range of pediatric and adult healthcare services including nursing, rehabilitation services, occupational nursing in schools, therapy services, day treatment centers for medically fragile and chronically ill children and adults, home health and hospice services, as well as delivery of enteral nutrition and other products to patients. The Company also provides case management services in order to assist families and patients by coordinating the provision of services between insurers or other payers, physicians, hospitals, and other healthcare providers. In addition, the Company provides respite healthcare services, which are temporary care provider services provided in relief of the patient’s normal caregiver. The Company’s services are designed to provide a high quality, lower cost alternative to prolonged hospitalization. For more information, please visit www.aveanna.com.


Risks

  • The company's reliance on insurance reimbursements and coordination with multiple healthcare providers may pose operational risks.
  • Participation in a leveraged finance conference suggests the company may have significant debt or financing activities, presenting financial risk.
  • Changes in healthcare regulations or funding could impact Aveanna's service delivery and profitability.

More from Press Releases

Agios Showcases RISE UP Phase 3 Results at EHA 2026 Plenary Session Reinforcing Strong Anti-Hemolytic Profile of Mitapivat in Sickle Cell Disease Jun 13, 2026 Rhythm Pharmaceuticals Presents Positive Interim Six-month Data from Phase 2 Trial of Setmelanotide in Patients with Prader-Willi Syndrome (PWS) at ENDO 2026 Jun 13, 2026 Intellia Therapeutics Reports Additional Positive Phase 3 Results for Lonvoguran Ziclumeran (lonvo-z) in Patients with Hereditary Angioedema Jun 13, 2026 Arcadia Biosciences (RKDA) Announces Closing of $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules Jun 12, 2026 Belite Bio Completes Rolling Submission of New Drug Application to U.S. Food and Drug Administration for Tinlarebant for the Treatment of Stargardt Disease Type 1 Jun 12, 2026